Curcumin Induces Ferroptosis in Follicular Thyroid Cancer by Upregulating HO-1 Expression

Oxid Med Cell Longev. 2023 Jan 14:2023:6896790. doi: 10.1155/2023/6896790. eCollection 2023.

Abstract

Follicular thyroid cancer (FTC) is a highly aggressive type of endocrine malignancy. It is necessary to investigate the mechanisms of tumorigenesis and therapeutic pathways in patients with FTC. Haem oxygenase-1 (HO-1) can regulate oxidative stress and the occurrence of tumors and diseases. In this study, we discovered that HO-1 was abnormally overexpressed in FTC compared with adjacent tissues. However, the HO-1 overexpression was demonstrated to decrease cell viability and to potentially activate the ferroptosis signalling pathway. Ferroptosis is a newly identified form of oxidative cell death and is currently being targeted as a new cancer treatment. Tumorigenesis is significantly inhibited by curcumin. The present study shows that curcumin inhibits the growth of FTC by increasing the HO-1 expression, further activating the ferroptosis pathway. This study demonstrates that the HO-1-ferroptosis signalling pathway might play an important role in FTC tumorigenesis, and that curcumin inhibits the growth of FTC cells by affecting this pathway.

MeSH terms

  • Adenocarcinoma, Follicular* / pathology
  • Carcinogenesis
  • Curcumin* / pharmacology
  • Ferroptosis*
  • Heme Oxygenase-1
  • Humans
  • Thyroid Neoplasms* / pathology

Substances

  • Curcumin
  • Heme Oxygenase-1

Supplementary concepts

  • Thyroid cancer, follicular